CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in prevalence of chronic and infectious disease
3.5.1.2. Increase in number of approval for the over-the-counter tests product
3.5.1.3. Advancement in technology to develop over-the-counter tests product
3.5.1.4. Surge in demand for early diagnosis of disease
3.5.2. Restraints
3.5.2.1. High cost of diagnostic instruments
3.5.2.2. Lack of awareness about technology among individual
3.5.3. Opportunities
3.5.3.1. Increase in healthcare expenditure worldwide
3.5.3.2. Development of advanced at-home testing devices by key players
3.5.4. Impact analysis
3.6. Impact analysis of COVID-19 on the over-the-counter tests market
CHAPTER 4: OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE
4.1. overview
4.1.1. Market size and forecast
4.1.2. Market Volume and forecast
4.2. Glucose Monitoring Tests
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Glucose Monitoring Tests, by Type
4.2.2.1. Market size and forecast
4.2.2.2. Market volume and forecast
4.2.2.3. Blood Glucose meters
4.2.2.3.1. Market size and forecast
4.2.2.4. Testing strips
4.2.2.4.1. Market size and forecast
4.2.2.5. Lancets
4.2.2.5.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market volume and forecast, by region
4.2.5. Market analysis, by country
4.3. Pregnancy & Fertility Tests
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Pregnancy and Fertility Tests, by Type
4.3.2.1. Market size and forecast
4.3.2.2. Market volume and forecast
4.3.2.3. Pregnancy Test
4.3.2.3.1. Market size and forecast
4.3.2.4. Fertility Test
4.3.2.4.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market volume and forecast, by region
4.3.5. Market analysis, by country
4.4. Coagulation Monitoring Tests
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market volume and forecast, by region
4.4.4. Market analysis, by country
4.5. Urinalysis Tests
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market volume and forecast, by region
4.5.4. Market analysis, by country
4.6. Cholesterol Tests
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market volume and forecast, by region
4.6.4. Market analysis, by country
4.7. Other Tests
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market volume and forecast, by region
4.7.4. Market analysis, by country
CHAPTER 5: OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY
5.1. overview
5.1.1. Market size and forecast
5.2. Lateral Flow Assays
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Immunoassays
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
5.4. Dipsticks
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market analysis, by country
CHAPTER 6: OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL
6.1. overview
6.1.1. Market size and forecast
6.2. Hospital Pharmacies
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3. Retail Pharmacies
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. Online Pharmacies
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
CHAPTER 7: OVER-THE-COUNTER TESTS MARKET, BY REGION
7.1. overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America over-the-counter tests market, by product type
7.2.3. North America over-the-counter tests market, by technology
7.2.4. North America over-the-counter tests market, by distribution channel
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. U.S. over-the-counter tests market, by product type
7.2.5.1.2. U.S. over-the-counter tests market, by technology
7.2.5.1.3. U.S. over-the-counter tests market, by distribution channel
7.2.5.2. Canada
7.2.5.2.1. Canada over-the-counter tests market, by product type
7.2.5.2.2. Canada over-the-counter tests market, by technology
7.2.5.2.3. Canada over-the-counter tests market, by distribution channel
7.2.5.3. Mexico
7.2.5.3.1. Mexico over-the-counter tests market, by product type
7.2.5.3.2. Mexico over-the-counter tests market, by technology
7.2.5.3.3. Mexico over-the-counter tests market, by distribution channel
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe over-the-counter tests market, by product type
7.3.3. Europe over-the-counter tests market, by technology
7.3.4. Europe over-the-counter tests market, by distribution channel
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Germany over-the-counter tests market, by product type
7.3.5.1.2. Germany over-the-counter tests market, by technology
7.3.5.1.3. Germany over-the-counter tests market, by distribution channel
7.3.5.2. France
7.3.5.2.1. France over-the-counter tests market, by product type
7.3.5.2.2. France over-the-counter tests market, by technology
7.3.5.2.3. France over-the-counter tests market, by distribution channel
7.3.5.3. UK
7.3.5.3.1. UK over-the-counter tests market, by product type
7.3.5.3.2. UK over-the-counter tests market, by technology
7.3.5.3.3. UK over-the-counter tests market, by distribution channel
7.3.5.4. Italy
7.3.5.4.1. Italy over-the-counter tests market, by product type
7.3.5.4.2. Italy over-the-counter tests market, by technology
7.3.5.4.3. Italy over-the-counter tests market, by distribution channel
7.3.5.5. Spain
7.3.5.5.1. Spain over-the-counter tests market, by product type
7.3.5.5.2. Spain over-the-counter tests market, by technology
7.3.5.5.3. Spain over-the-counter tests market, by distribution channel
7.3.5.6. Rest of Europe
7.3.5.6.1. Rest of Europe over-the-counter tests market, by product type
7.3.5.6.2. Rest of Europe over-the-counter tests market, by technology
7.3.5.6.3. Rest of Europe over-the-counter tests market, by distribution channel
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific over-the-counter tests market, by product type
7.4.3. Asia-Pacific over-the-counter tests market, by technology
7.4.4. Asia-Pacific over-the-counter tests market, by distribution channel
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. China over-the-counter tests market, by product type
7.4.5.1.2. China over-the-counter tests market, by technology
7.4.5.1.3. China over-the-counter tests market, by distribution channel
7.4.5.2. Japan
7.4.5.2.1. Japan over-the-counter tests market, by product type
7.4.5.2.2. Japan over-the-counter tests market, by technology
7.4.5.2.3. Japan over-the-counter tests market, by distribution channel
7.4.5.3. India
7.4.5.3.1. India over-the-counter tests market, by product type
7.4.5.3.2. India over-the-counter tests market, by technology
7.4.5.3.3. India over-the-counter tests market, by distribution channel
7.4.5.4. Australia
7.4.5.4.1. Australia over-the-counter tests market, by product type
7.4.5.4.2. Australia over-the-counter tests market, by technology
7.4.5.4.3. Australia over-the-counter tests market, by distribution channel
7.4.5.5. South Korea
7.4.5.5.1. South Korea over-the-counter tests market, by product type
7.4.5.5.2. South Korea over-the-counter tests market, by technology
7.4.5.5.3. South Korea over-the-counter tests market, by distribution channel
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Rest of Asia-Pacific over-the-counter tests market, by product type
7.4.5.6.2. Rest of Asia-Pacific over-the-counter tests market, by technology
7.4.5.6.3. Rest of Asia-Pacific over-the-counter tests market, by distribution channel
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA over-the-counter tests market, by product type
7.5.3. LAMEA over-the-counter tests market, by technology
7.5.4. LAMEA over-the-counter tests market, by distribution channel
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Brazil over-the-counter tests market, by product type
7.5.5.1.2. Brazil over-the-counter tests market, by technology
7.5.5.1.3. Brazil over-the-counter tests market, by distribution channel
7.5.5.2. Saudi Arabia
7.5.5.2.1. Saudi Arabia over-the-counter tests market, by product type
7.5.5.2.2. Saudi Arabia over-the-counter tests market, by technology
7.5.5.2.3. Saudi Arabia over-the-counter tests market, by distribution channel
7.5.5.3. South Africa
7.5.5.3.1. South Africa over-the-counter tests market, by product type
7.5.5.3.2. South Africa over-the-counter tests market, by technology
7.5.5.3.3. South Africa over-the-counter tests market, by distribution channel
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Rest of LAMEA over-the-counter tests market, by product type
7.5.5.4.2. Rest of LAMEA over-the-counter tests market, by technology
7.5.5.4.3. Rest of LAMEA over-the-counter tests market, by distribution channel
CHAPTER 8: COMPANY PROFILES
8.1. Abbott Laboratories
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. Abingdon Health PLC
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. AccuBioTech Co., Ltd
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Key strategic moves and developments
8.4. Acon Laboratories, INC.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. B. Braun Melsungen AG
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. Becton, Dickinson and Company
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Clip Health
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.8. Dario Health Corp.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. Ellume Health Ltd.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Key strategic moves and developments
8.10. Eurofins Scientific Group
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
8.11. F. Hoffmann-La Roche AG (Roche Diagnostics)
8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Operating business segments
8.11.4. Product portfolio
8.11.5. Business performance
8.11.6. Key strategic moves and developments
8.12. Lia Diagnostics Inc.
8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Operating business segments
8.12.4. Product portfolio
8.13. LifeScan IP Holdings, LLC
8.13.1. Company overview
8.13.2. Company snapshot
8.13.3. Operating business segments
8.13.4. Product portfolio
8.13.5. Key strategic moves and developments
8.14. Lucira Health, Inc.
8.14.1. Company overview
8.14.2. Company snapshot
8.14.3. Operating business segments
8.14.4. Product portfolio
8.14.5. Business performance
8.14.6. Key strategic moves and developments
8.15. Now Diagnostics Inc.
8.15.1. Company overview
8.15.2. Company snapshot
8.15.3. Operating business segments
8.15.4. Product portfolio
8.15.5. Key strategic moves and developments
8.16. Orasure Technologies Inc.
8.16.1. Company overview
8.16.2. Company snapshot
8.16.3. Operating business segments
8.16.4. Product portfolio
8.16.5. Business performance
8.16.6. Key strategic moves and developments
8.17. PHC Holdings Corporation
8.17.1. Company overview
8.17.2. Company snapshot
8.17.3. Operating business segments
8.17.4. Product portfolio
8.17.5. Key strategic moves and developments
8.18. Quidel Corporation
8.18.1. Company overview
8.18.2. Company snapshot
8.18.3. Operating business segments
8.18.4. Product portfolio
8.18.5. Business performance
8.18.6. Key strategic moves and developments
8.19. SD Biosensor, Inc.
8.19.1. Company overview
8.19.2. Company snapshot
8.19.3. Operating business segments
8.19.4. Product portfolio
8.19.5. Business performance
8.19.6. Key strategic moves and developments
8.20. Sinocare Inc.
8.20.1. Company overview
8.20.2. Company snapshot
8.20.3. Operating business segments
8.20.4. Product portfolio
List of Tables
TABLE 01. GLOBAL OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 02. GLOBAL OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 (UNITS)
TABLE 03. OVER-THE-COUNTER TEST MARKET FOR GLUCOSE MONITORING TESTS BY TYPE, 2020-2030 ($MILLION)
TABLE 04. OVER-THE-COUNTER TEST MARKET FOR GLUCOSE MONITORING TESTS BY TYPE, 2020-2030 (UNITS)
TABLE 05. OVER-THE-COUNTER TESTS MARKET FOR GLUCOSE MONITORING TESTS, BY REGION, 2020-2030 ($MILLION)
TABLE 06. OVER-THE-COUNTER TESTS MARKET FOR GLUCOSE MONITORING TESTS, BY REGION, 2020-2030 (UNITS)
TABLE 07. OVER-THE-COUNTER TEST MARKET FOR PREGNANCY & FERTILITY TESTS BY TYPE, 2020-2030 ($MILLION)
TABLE 08. OVER-THE-COUNTER TEST MARKET FOR PREGNANCY & FERTILITY TESTS BY TYPE, 2020-2030 (UNITS)
TABLE 09. OVER-THE-COUNTER TEST MARKET FOR PREGNANCY AND FERTILITY TESTS, BY REGION, 2020-2030 ($MILLION)
TABLE 10. OVER-THE-COUNTER TEST MARKET FOR PREGNANCY AND FERTILITY TESTS, BY REGION, 2020-2030 (UNITS)
TABLE 11. OVER-THE-COUNTER TESTS MARKET FOR COAGULATION MONITORING TESTS, BY REGION, 2020-2030 ($MILLION)
TABLE 12. OVER-THE-COUNTER TEST MARKET FOR COAGULATION MONITORING TESTS, BY REGION, 2020-2030 (UNITS)
TABLE 13. OVER-THE-COUNTER TESTS MARKET FOR URINALYSIS TESTS, BY REGION, 2020-2030 ($MILLION)
TABLE 14. OVER-THE-COUNTER TEST MARKET FOR URINALYSIS TESTS, BY REGION, 2020-2030 (UNITS)
TABLE 15. OVER-THE-COUNTER TESTS MARKET FOR CHOLESTEROL TESTS, BY REGION, 2020-2030 ($MILLION)
TABLE 16. OVER-THE-COUNTER TEST MARKET FOR CHOLESTEROL TESTS, BY REGION, 2020-2030 (UNITS)
TABLE 17. OVER-THE-COUNTER TESTS MARKET FOR OTHER TESTS, BY REGION, 2020-2030 ($MILLION)
TABLE 18. OVER-THE-COUNTER TEST MARKET FOR OTHERS TEST, BY REGION, 2020-2030 (UNITS)
TABLE 19. GLOBAL OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 20. OVER-THE-COUNTER TESTS MARKET FOR LATERAL FLOW ASSAYS, BY REGION, 2020-2030 ($MILLION)
TABLE 21. OVER-THE-COUNTER TESTS MARKET FOR IMMUNOASSAYS, BY REGION, 2020-2030 ($MILLION)
TABLE 22. OVER-THE-COUNTER TESTS MARKET FOR DIPSTICKS, BY REGION, 2020-2030 ($MILLION)
TABLE 23. GLOBAL OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 24. OVER-THE-COUNTER TESTS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2020-2030 ($MILLION)
TABLE 25. OVER-THE-COUNTER TESTS MARKET FOR RETAIL PHARMACIES, BY REGION, 2020-2030 ($MILLION)
TABLE 26. OVER-THE-COUNTER TESTS MARKET FOR ONLINE PHARMACIES, BY REGION, 2020-2030 ($MILLION)
TABLE 27. OVER-THE-COUNTER TESTS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 28. NORTH AMERICA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 29. NORTH AMERICA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 30. NORTH AMERICA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 31. NORTH AMERICA OVER-THE-COUNTER TESTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 32. U.S. OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 33. U.S. OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 34. U.S. OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 35. CANADA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 36. CANADA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 37. CANADA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 38. MEXICO OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 39. MEXICO OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 40. MEXICO OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 41. EUROPE OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 42. EUROPE OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 43. EUROPE OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 44. EUROPE OVER-THE-COUNTER TESTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 45. GERMANY OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 46. GERMANY OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 47. GERMANY OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 48. FRANCE OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 49. FRANCE OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 50. FRANCE OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 51. UK OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 52. UK OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 53. UK OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 54. ITALY OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 55. ITALY OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 56. ITALY OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 57. SPAIN OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 58. SPAIN OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 59. SPAIN OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 60. REST OF EUROPE OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 61. REST OF EUROPE OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 62. REST OF EUROPE OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 63. ASIA-PACIFIC OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 64. ASIA-PACIFIC OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 65. ASIA-PACIFIC OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 66. ASIA-PACIFIC OVER-THE-COUNTER TESTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 67. CHINA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 68. CHINA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 69. CHINA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 70. JAPAN OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 71. JAPAN OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 72. JAPAN OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 73. INDIA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 74. INDIA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 75. INDIA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 76. AUSTRALIA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 77. AUSTRALIA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 78. AUSTRALIA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 79. SOUTH KOREA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 80. SOUTH KOREA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 81. SOUTH KOREA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 82. REST OF ASIA-PACIFIC OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 83. REST OF ASIA-PACIFIC OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 84. REST OF ASIA-PACIFIC OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 85. LAMEA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 86. LAMEA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 87. LAMEA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 88. LAMEA OVER-THE-COUNTER TESTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 89. BRAZIL OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 90. BRAZIL OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 91. BRAZIL OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 92. SAUDI ARABIA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 93. SAUDI ARABIA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 94. SAUDI ARABIA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 95. SOUTH AFRICA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 96. SOUTH AFRICA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 97. SOUTH AFRICA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 98. REST OF LAMEA OVER-THE-COUNTER TESTS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 99. REST OF LAMEA OVER-THE-COUNTER TESTS MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 100. REST OF LAMEA OVER-THE-COUNTER TESTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 101. ABBOTT: COMPANY SNAPSHOT
TABLE 102. ABBOTT: OPERATING SEGMENTS
TABLE 103. ABBOTT: PRODUCT PORTFOLIO
TABLE 104. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. ABINGDON HEALTH: COMPANY SNAPSHOT
TABLE 106. ABINGDON HEALTH: OPERATING SEGMENTS
TABLE 107. ABINGDON HEALTH: PRODUCT PORTFOLIO
TABLE 108. ABINGDON HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 109. ACCUBIOTECH: COMPANY SNAPSHOT
TABLE 110. ACCUBIOTECH: OPERATING SEGMENTS
TABLE 111. ACCUBIOTECH: PRODUCT PORTFOLIO
TABLE 112. ACCUBIOTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 113. ACON LABORATORIES: COMPANY SNAPSHOT
TABLE 114. ACON LABORATORIES: OPERATING SEGMENTS
TABLE 115. ACON LABORATORIES: PRODUCT PORTFOLIO
TABLE 116. ACON LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 117. B. BRAUN: COMPANY SNAPSHOT
TABLE 118. B. BRAUN: OERATING SEGMENT
TABLE 119. B. BRAUN: PRODUCT PORTFOLIO
TABLE 120. BD: COMPANY SNAPSHOT
TABLE 121. BD: OPERATING SEGMENTS
TABLE 122. BD: PRODUCT PORTFOLIO
TABLE 123. BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124. CLIP HEALTH: COMPANY SNAPSHOT
TABLE 125. CLIP HEALTH: OERATING SEGMENT
TABLE 126. CLIP HEALTH: PRODUCT PORTFOLIO
TABLE 127. CLIP HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 128. DARIO HEALTH: COMPANY SNAPSHOT
TABLE 129. DARIO HEALTH: OERATING SEGMENT
TABLE 130. DARIO HEALTH: PRODUCT PORTFOLIO
TABLE 131. ELLUME HEALTH: COMPANY SNAPSHOT
TABLE 132. ELLUME HEALTH: OERATING SEGMENT
TABLE 133. ELLUME HEALTH: PRODUCT PORTFOLIO
TABLE 134. ELLUME HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 135. EUROFINS: COMPANY SNAPSHOT
TABLE 136. EUROFINS: OPERATING SEGMENTS
TABLE 137. EUROFINS: PRODUCT PORTFOLIO
TABLE 138. EUROFINS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 139. ROCHE: COMPANY SNAPSHOT
TABLE 140. ROCHE: OPERATING SEGMENTS
TABLE 141. ROCHE: PRODUCT PORTFOLIO
TABLE 142. ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 143. LIA DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 144. LIA DIAGNOSTICS: OPERATING SEGMENTS
TABLE 145. LIA DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 146. LIFESCAN IP: COMPANY SNAPSHOT
TABLE 147. LIFESCAN IP: OERATING SEGMENT
TABLE 148. LIFESCAN IP: PRODUCT PORTFOLIO
TABLE 149. LIFESCAN IP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 150. LUCIRA HEALTH: COMPANY SNAPSHOT
TABLE 151. LUCIRA HEALTH: OPERATING SEGMENTS
TABLE 152. LUCIRA HEALTH: PRODUCT PORTFOLIO
TABLE 153. LUCIRA HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 154. NOW DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 155. NOW DIAGNOSTICS: OPERATING SEGMENTS
TABLE 156. NOW DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 157. NOW DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 158. ORASURE TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 159. ORASURE TECHNOLOGIES: OERATING SEGMENT
TABLE 160. ORASURE TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 161. ORASURE TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 162. PHC HOLDINGS: COMPANY SNAPSHOT
TABLE 163. PHC HOLDINGS: OPERATING SEGMENTS
TABLE 164. PHC HOLDINGS: PRODUCT PORTFOLIO
TABLE 165. PHC HOLDINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 166. QUIDEL: COMPANY SNAPSHOT
TABLE 167. QUIDEL: OPERATING SEGMENTS
TABLE 168. QUIDEL: PRODUCT PORTFOLIO
TABLE 169. QUIDEL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 170. SD BIOSENSOR: COMPANY SNAPSHOT
TABLE 171. SD BIOSENSOR: OPERATING SEGMENTS
TABLE 172. SD BIOSENSOR: PRODUCT PORTFOLIO
TABLE 173. SD BIOSENSOR: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 174. SINOCARE: COMPANY SNAPSHOT
TABLE 175. SINOCARE: OERATING SEGMENT
TABLE 176. SINOCARE: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. OVER-THE-COUNTER TESTS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2019-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. OVER-THE-COUNTER TEST MARKET FOR BLOOD GLUCOSE METERS, 2020-2030 ($MILLION)
FIGURE 14. OVER-THE-COUNTER TEST MARKET FOR TESTING STRIPS, 2020-2030 ($MILLION)
FIGURE 15. OVER-THE-COUNTER TEST MARKET FOR LANCETS, 2020-2030 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR GLUCOSE MONITORING TESTS, BY COUNTRY, 2020-2030 (%)
FIGURE 17. OVER-THE-COUNTER TESTS MARKET FOR PREGNANCY TEST, 2020-2030 ($MILLION)
FIGURE 18. OVER-THE-COUNTER TESTS MARKET FOR FERTILITY TEST, 2020-2030 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2020-2030 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR COAGULATION MONITORING TESTS, BY COUNTRY, 2020-2030 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR URINALYSIS TESTS, BY COUNTRY, 2020-2030 (%)
FIGURE 22. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR CHOLESTEROL TESTS, BY COUNTRY, 2020-2030 (%)
FIGURE 23. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR OTHER TESTS, BY COUNTRY, 2020-2030 (%)
FIGURE 24. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2020-2030 (%)
FIGURE 25. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2020-2030 (%)
FIGURE 26. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR DIPSTICKS, BY COUNTRY, 2020-2030 (%)
FIGURE 27. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2020-2030 (%)
FIGURE 28. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2020-2030 (%)
FIGURE 29. COMPARATIVE ANALYSIS OF OVER-THE-COUNTER TESTS MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2020-2030 (%)
FIGURE 30. ABBOTT: NET SALES, 2018-2020 ($MILLION)
FIGURE 31. ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32. ABBOTT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 33. ABINGDON HEALTH: NET SALES, 2018-2020 ($MILLION)
FIGURE 34. ABINGDON HEALTH: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35. ABINGDON HEALTH: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 36. B. BRAUN: NET SALES, 2018-2020 ($MILLION)
FIGURE 37. B. BRAUN: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 38. B. BRAUN: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 39. BD: NET SALES, 2018-2020 ($MILLION)
FIGURE 40. BD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 41. BD: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 42. DARIO HEALTH: NET SALES, 2018-2020 ($MILLION)
FIGURE 43. EUROFINS: NET SALES, 2018-2020 ($MILLION)
FIGURE 44. EUROFINS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 45. ROCHE: NET SALES, 2018-2020 ($MILLION)
FIGURE 46. ROCHE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 47. ROCHE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 48. LUCIRA HEALTH: NET SALES, 2018-2020 ($MILLION)
FIGURE 49. ORASURE TECHNOLOGIES: NET SALES, 2018-2020 ($MILLION)
FIGURE 50. ORASURE TECHNOLOGIES: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 51. ORASURE TECHNOLOGIES: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 52. QUIDEL: NET SALES, 2018-2020 ($MILLION)
FIGURE 53. QUIDEL: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 54. SD BIOSENSOR: NET SALES, 2018-2020 ($MILLION)
